Copyright © Inderes 2011 - present. All rights reserved.

Remedy Entertainment

13,3

 

EUR

 

-0,75 %

Corporate customer

REMEDY

NASDAQ Helsinki

Software

Technology

11.233 investorer følger denne virksomhed
Sammenligne
-0,75%
+3,1%
-21,21%
-24,69%
-47,64%
-44,81%
-62,05%
+20,36%
+98,8%

Remedy Entertainment is a game developer. The business is primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games developed by the company include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and utility technology that powers many of the games. The company was founded in 1995 and has its headquarters in Espoo.

Læs mere
Markedsværdi
180,54 mio. EUR
Aktieomsætning
320,52 t EUR
P/E (adj.) (24e)
-32,09
EV/EBIT (adj.) (24e)
-24,47
P/B (24e)
2,91
EV/S (24e)
3,59
Udbytteafkast, % (24e)
-
Coverage
Anbefaling
Køb
Kursmål
19.00 EUR
Opdateret
17.12.2024
Disclaimer
Latest research

Latest analysis report

Released: 20.11.2024

Latest extensive report

Released: 18.12.2024

Finanskalender
12.2
2025

Årsrapport '24

10.4
2025

Generalforsamling '24

30.4
2025

Selskabsgennemgang Q1'25

Risiko
Business risk
Valuation risk
Lav
Høj
ViserAlle indholdstyper
Omfattende analyse af
Atte Riikola

Remedy extensive report: No game, no fame

Over the years, Remedy has demonstrated its ability to develop games of very high quality, but this has not yet been reflected to the same extent in their commercial success for the company. As a result of years of work, the company has built its capabilities and resources to support a more frequent, even annual pace of new game releases over the 2025-2030 strategy period.

Remedy Entertainment

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Analyse af
Atte Riikola

Remedy Q3'24: Long-term potential is building

The company's Q3 results were well above expectations and the game projects in development are progressing well. However, the sales performance of Alan Wake 2 has been disappointing compared to our expectations, and the company now has something to prove during the crucial sales months at the end of the year.

Remedy Entertainment
Remedy Q3'24 flash comment: Figures above expectations, but AW2 sales development disappointing
Analytikerkommentar af
Atte Riikola

Remedy Q3'24 flash comment: Figures above expectations, but AW2 sales development disappointing

Remedy reported significantly stronger Q3 figures this morning than we expected, as more development fees from the Control 2 project were recognized in the quarter than we anticipated. The company's game projects are also progressing in line with our expectations. On the negative side, Alan Wake 2 has not yet recouped its development and marketing budget, and now sales expectations are focused on the crucial November-December window.

Remedy Entertainment
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.